Determination of omeprazole via fluorescence-quenching methodology; application to content uniformity testing

Luminescence. 2024 Feb;39(2):e4682. doi: 10.1002/bio.4682.

Abstract

A new, proven, economical spectrofluorimetric approach has been used to determine the proton pump inhibitor omeprazole (OMP). This innovative technique is based on the ability of OMP to quench the native fluorescence of the mercurochrome dye in an acidic (pH 3.6) solution. Because it was discovered that quenching is proportional to the drug concentration, this dye was used as a sensor for OMP detection. The fluorescence intensity was measured at 518/540 nm, and its linear response ranged from 0.2-10.0 μg/mL with a linear coefficient of 0.9999. The computation yielded a limit of quantification (LOQ) of 0.20 μg/mL and a limit of detection (LOD) of 0.07 μg/mL. Every circumstance and element impacting the reaction product was examined in detail. Pharmacopeial standards carried out the validation. The approved method investigated several commercial preparations and formulations, and the results were favorably compared with those provided by a reference method. According to United States Pharmacopeia (USP) rules, content consistency for two distinct formulations was evaluated.

Keywords: content uniformity; fluorescence; mercurochrome; omeprazole.

MeSH terms

  • Limit of Detection
  • Omeprazole*
  • Spectrometry, Fluorescence / methods
  • Tablets / chemistry

Substances

  • Omeprazole
  • Tablets